CIK 0001661998
- Non-accelerated filer
- Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473468154
- Phone
- +1 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $320,396
- in 6 filings
Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-01 | Smith W Bradford CFO & Treasurer | Exercise or conversion · Restricted Stock Units | −6,600 | 13,400 | ||
| 2022-01-01 | Kelly Timothy P Chief Operating Officer | Exercise or conversion | +3,630 | 3,630 | ||
| 2022-01-01 | Kelly Timothy P Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −3,630 | 7,370 | ||
| 2022-01-01 | Seymour Albert Chief Scientific Officer | Exercise or conversion | +4,290 | 133,307 | ||
| 2022-01-01 | Seymour Albert Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −4,290 | 8,710 | ||
| 2022-01-01 | Cohn Gabriel Chief Medical Officer | Exercise or conversion | +4,290 | 4,290 | ||
| 2022-01-01 | Cohn Gabriel Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −4,290 | 8,710 | ||
| 2022-01-01 | TZIANABOS ARTHUR President & CEO | Exercise or conversion | +13,860 | 91,365 | ||
| 2022-01-01 | TZIANABOS ARTHUR President & CEO | Exercise or conversion · Restricted Stock Units | −13,860 | 28,140 | ||
| 2021-09-03 | Kelly Timothy P | Sale | −54 | $7.70 | $416 | 0 |
| 2021-06-17 | Gregory Richard J. Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-17 | PARMAR KUSH Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-17 | Patterson Matthew R Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-17 | REICIN ALISE Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-17 | Poulton Jeffrey V. Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-17 | Thistle Mary Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-06-17 | GILLIS STEVEN Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-04-07 | Kelly Timothy P Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-03-01 | Kelly Timothy P | Sale | −6,232 | $11.16 | $70K | 0 |
| 2021-03-01 | Kelly Timothy P | Exercise or conversion | +2,000 | $6.63 | $13K | 4,232 |
Page 14 of 25 · 492 trades